NovoGI

About:

NovoGI develops medical devices and services that focus on gastrointestinal disease management.

Website: http://www.novogi.com/

Top Investors: Forbion Capital Partners, Cipio Partners, Evergreen Venture Partners, Israel Healthcare Ventures, SCP Vitalife Partners

Description:

novoGI™ (previously NiTi Surgical Solutions) is committed to advancing patient care by providing an expanding range of comprehensive solutions for GI disease management. NiTi Surgical Solutions has developed the first major advance in closure for gastrointestinal surgery in more than 30 years. NiTi's proprietary technology represents a breakthrough in natural healing with tissue-sparing, uniform BioDynamix anastomosis. The company's unique line of products utilizes Nitinol-based elements to press together the ends of resected tissue, enabling a natural reconnection of the intestine after removing a section, for example, as part of a colon cancer treatment. The company is commercializing a family of FDA-cleared and CE-marked disposable tissue closure devices.

Total Funding Amount:

$18.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Netanya, HaMerkaz, Israel

Founded Date:

1996-01-01

Contact Email:

niti(AT)nitisurgical.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2009-08-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai